Garry Michael Walsh

Garry Michael Walsh

Garry Michael Walsh, PhD
Section of Immunology & Infection, Division of Applied Medicine
University of Aberdeen, UK


Dr Walsh is Reader Associate Professor in Inflammation Immunity and Principal Investigator of the Asthmatic Allergic Inflammation Group School of Medicine Dentistry University of Aberdeen UK His group is part of the Immunology Research Programme within the Division of Applied Medicine that was rated fourth equal in the UK in the 2008 research assessment exercise Dr Walsh is honorary Professor of Inflammation Immunity School of Medicine Trinity College Dublin Ireland His major research interests involve elucidation of the molecular mechanisms controlling the initiation and resolution of the inflammatory processes underlying asthma COPD and allergic disease Dr Walsh has published over 60 peerreviewed articles in international journals together with more than 80 invited editorials reviews and book chapters To date these publications have been cited over 3300 times; giving an hindex of 33 source ISI Web of Knowledge Dr Walsh has been an invited speaker and/or chairman at over fifty international meetings In addition to his role as the EditorinChief of Therapeutics and Clinical Risk Management he is the Founding Editor of the Journal of Cell Death; and Clinical Medicine Therapeutics He is also an Editorial Board Member of the Journal of Allergy Section Head International Journal of Biomedical Science Biologics: targets and therapy The Open Immunology Journal The Open Inflammation Journal The Open Allergy Journal and the Journal of Organ Dysfunction Dr Walsh is a regular reviewer for over 40 clinical and scientific journals and serves as a grant reviewer for UK and international funding bodies Since 2003 he has been a European Commission evaluation expert for FP6 and FP7 and is currently ViceChair of the Evaluation Panel for Marie Curie Reintegration Mobility Actions Dr Walsh was a Member of the MRC College of Experts affiliated to the Infection and Immunity Board and a Member of Lung Cellular and Molecular Immunology LCMI Special Emphasis Panel National Institutes of Health USA

Research Interest

Differentiated human bronchial epithelial cells;Airway epithelial cell phenotype;Biomarkers in asthma and COPD;Eosinophil and neutrophil adhesion and transmigration under flow;Eosinophil apoptosis and phagocytic recognition/disposal;Novel anti-inflammatory effects of currently available drugs